CTOs on the Move

University HealthSystem Consortium

www.uhc.edu

 
UHC, based in Oak Brook, Ill., and representing 0.7 of the academic medical centers in the United States, is an alliance of 84 academic medical centers and 80 associate members.
  • Number of Employees: 1K-5K
  • Annual Revenue: $0-1 Million
  • www.uhc.edu
  • 2001 Spring Rd Ste 700
    Oak Brook, IL USA 60523-1890
  • Phone: 630.954.1700

Executives

Name Title Contact Details

Similar Companies

Clinicas De Salud Del Pueblo

Clinicas De Salud Del Pueblo, Inc. is a Brawley, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medivia

Medivia is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Marks Gray P.A

Marks Gray P.A is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Blueprint Medicines

Blueprint Medicines is developing a new generation of highly selective and potent kinase therapies to dramatically improve the lives of patients with genomically defined diseases. Our approach is rooted in a deep understanding of the genetic blueprint of cancer and other diseases driven by the abnormal activation of kinases. Our ability to identify novel drivers of disease, coupled with our proprietary library of novel and diverse chemical compounds, uniquely enables us to craft kinase therapies against new and difficult-to-drug targets. We are boldly advancing a deep pipeline of highly targeted therapies against previously unaddressed drivers of disease. By focusing on genomically defined subsets of patients, we believe we can identify the people most likely to respond to our therapies, resulting in a more efficient clinical development path with a greater likelihood of success and better outcomes for patients. We see a substantial opportunity in kinase drug discovery and development to deliver breakthrough medicines that allow patients to live longer with better quality of life and prevent recurrences of disease. Kinases are involved in many hallmarks of tumor biology and are proven cancer drug targets. Currently approved drugs focus on less than 5 percent of known kinases, and the function of most kinases is unknown. Led by a team of industry innovators with a track record of bringing life-changing drugs to market, we believe Blueprint Medicines has the experience and expertise to deliver on the tremendous untapped potential of kinase therapies to improve patients’ lives. We don’t think in small steps. We think in giant leaps. We are driven by the pursuit of new ideas, new innovations, and new ways of thinking.

Encompass Group

For nearly a century, Encompass has been helping health care and hospitality organizations create safe, comfortable environments for patients, staff, residents and guests. Whether developing advanced hypothermia prevention products, helping hospitals contain the spread of infections, or designing interiors for new, state-of-the-art retirement communities, we offer a complete line of products, services and education programs that meet the challenges our customers face every day.